InvestorsHub Logo
Followers 84
Posts 11043
Boards Moderated 0
Alias Born 04/30/2007

Re: None

Monday, 12/07/2020 5:03:14 AM

Monday, December 07, 2020 5:03:14 AM

Post# of 5010
Kodak has admitted to other issues since then. Last month, the company said five former executives were able to collect millions of dollars by selling stock options they didn’t own due to weak internal controls that failed to prevent unauthorized issuance of the company’s stock. Kodak has said it would try to recover about $3.9 million from the ex-employees for the fair value of the shares at the time of the sale and about $3 million from the withholding of taxes on behalf of the ex-employees.
At a Journal conference in October, Kodak’s Chief Executive Jim Continenza defended his company’s handling of the loan plans and said that Kodak would move ahead in making drug ingredientsregardless of whether it receives government assistance.
Meanwhile, the DFC has announced a new loan in its coronavirus response. Last month, the agency said it approved a $590 million loan to ApiJect Systems Corp. to produce prefilled injectors for vaccines. The Food and Drug Administration hasn’t approved the devices for distribution though the company has been in discussions with the FDA, according to an ApiJect spokesman. The FDA didn’t respond to a request for comment.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KODK News